I built OncoMarker —an open tool to go from biomarker → recruiting clinical trials in seconds.
40+ biomarkers linked to live https://t.co/9rAzkuqm2S + OncoKB evidence.
Try it: https://t.co/QlLwqECOeT
#Oncology#HealthTech#OpenSource#PrecisionMedicine#ClinicalTrials
A cost-effectiveness assessment of using AI in disease screening (modeling)
"Implementing an annual ‘copilot’ strategy in all ages would save US$1.32 million while gaining 14.73 quality-adjusted life years over a lifetime [per 100,000 people]"
"Our findings demonstrate the indispensable role of human involvement in maximizing clinical benefits and cost-effectiveness in AI-driven medical applications."
https://t.co/hwovlHdZEd
A newly discovered blood stem cell subtype — HSC-iM — retains epigenetic memory of past inflammation (COVID, aging, infection) and passes it to immune progeny.
Your immune system doesn’t just fight inflammation. It remembers it.
https://t.co/RKDYxjcFxN
Excellent review on how immune checkpoint molecules shape tumor immune evasion and therapeutic response. understanding the regulatory mechanisms behind checkpoint expression is just as important as targeting the checkpoints themselves#ImmunoOncology #Cancerimmunotherapy
The idea that functional mitochondria themselves could become a therapeutic platform is fascinating . Especially for neurodegenerative disorders where effective treatments remain limited.
Good read!
In the latest issue! Transplantation of encapsulated mitochondria alleviates dysfunction in mitochondrial and Parkinson’s disease models https://t.co/DapcveO7EU
Are you a recent Ph.D. graduate? Apply for the Science & @scilifelab Prize for Young Scientists.
The $30,000 grand prize will be awarded for outstanding research in cell and molecular biology, genomics, ecology, or molecular medicine.
Apply by 15 July: https://t.co/CdWCJt0V2l
I don’t tweet much so I’ll keep this simple
We are looking to recruit 1-2 new postdoctoral fellows, to study human hematopoietic development, from both basic and translational perspectives, using iPSCs.
Please reach out via email for more details if interested!
Filed a U.S. provisional patent on a new class of ApoE4 structure correctors for Alzheimer’s. Computational so far , looking for collaborators to take it to the bench
Today, artificial intelligence can identify potential drug targets and develop medicines from scratch. But whether the approach can craft drugs that help patients remains to be seen.
https://t.co/599TBBWJKw
The USA is back on the Moon thanks to the IM-1 mission by @Int_Machines. This week their lunar lander launched on a @SpaceX rocket and touched down on the lunar surface. I appeared on @CNN to discuss this milestone event, set to open access to the Moon for the progress of humanity. #IM1 #MOONLANDING